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RNA-directed translational gene silencing in many organ-
isms appears to represent a later evolved function for this 
versatile  molecule,  and  the  observation  that  protein  do-
mains similar to those  of RISC complex components in 
Tetrahymena,  fission  yeast,  fungi  and  archaeal  bacteria 
suggests  that  RNA  interference  as it is  currently  under-
stood may have developed as a functional entity in the last 
common  ancestor  of  eukaryotes  (Cerutti  and  Casas-
Mollano, 2006). Crystal structures indicate that the PIWI 
domain  of  ARGONAUTE  proteins  is  a  member  of  the 
RNase  H  superfamily,  supporting  the  notion  that  RNAi 
evolved as a defense against genomic parasites (Parker et 
al, 2004; Cerutti and  Casas-Mollano,  2006). A range  of 
new studies are now beginning to reveal both a diversity of 
cellular  small  RNAs,  and  potential  functions  other  than 
translational silencing in higher organisms.  It is becoming 
increasingly apparent that the role of RNA in coordinating 
and  facilitating  a  wide  variety  of  cellular  processes  has 
been underestimated.  
 
Traditional exogenous short RNA mediated gene silencing 
efforts have been designed to target an mRNA sequence. 
Most endogenous miRNA also appear also to  target the 
transcribed RNA and so RNAi has generally been consid-
ered  a  post-transcriptional  regulatory  mechanism  (Bern-
stein et al, 2001; Broderson and Voinnet, 2006). Experi-
ments in fission yeast have showed that complexes con-
taining siRNAs can be co-purified with proteins involved 
in  transcriptional  silencing,  suggesting  that  small  RNAs 
might  have  nuclear  silencing  roles  also  (Reinhart  and 
Bartel,  2002;  Volpe  et  al,  2002).  Whilst  transcriptional 
regulation by RNA has been implied since the observation 
of RNA-induced DNA methylation in plants over 10 years 
ago, (Wassenegger, 1994), the relevance of this observa-
tion  to  small  RNAs  and  animal  cells  has  only  recently 
come into focus.  
 
Small RNAs play a role in histone H3 methylation at cen-
tromeres
 in S.pombe, indicating that such a mechanism is 
not  limited  to  plants  (Volpe  et  al,  2002;  Reinhart  and 
Bartel, 2002; Buhler et al, 2006). Experiments in C. ele-
gans  and  Drosophila  identified  potential  transcriptional 
regulatory  roles for  small  RNAs  that involve  chromatin 
modification (Pal-Bhadra et al, 2004; Grishok et al, 2005). 
RNAi-induced  Transcriptional  Gene  Silencing  (RNAi-
TGS)  in  C.  elegans  is  dependent  upon  heterochromatin 
factors,
  reduced by  histone deacetylase  inhibitors  and  is 
associated with a decrease in acetylated histone H4 protein 
and less
 polymerase II recruitment to the initiation com-
plex. Mutations in the RNAi pathway genes dcr-1, rde-1, 
rde-4,
 and rrf-1 refract RNAi-TGS, strongly indicating that 
this is a nuclear mechanism of transcriptional regulation 
mediated by the RNAi machinery (Grishok et al, 2005).  
 
The  experimental  application  of  RNA  interference  has 
become routine, but several new observations suggest that 
small  RNAs  might induce  unappreciated cellular  effects 
such as sequence specific transcriptional silencing or acti-
vation.  Twenty-one  nucleotide  dsRNA  targeted  to  the 
promoter  regions  of  stably  transfected  CCR5  and 
RASSF1A or endogenous Huntingtin, Androgen receptor 
or Progesterone receptor loci represses transcription in cell 
culture, whilst at the  promoters  of E-Cadherin,  p21 and 
VEGF genes, exogenous dsRNA enhances the steady state 
level  of  transcription  (Janowski  et  al,  2006;  Kim  et  al, 
2006; Li et al, 2006) .  
 
Answering  the  question  of  whether  these  observations 
result from currently  documented  silencing  mechanisms, 
or  represent  novel  (perhaps  endogenous)  pathways  of 
small RNA regulation is of some significance as, if borne 
out, the findings might offer a means to specifically acti-
vate transcription with small RNAs in an analogous man-




Demonstration of transcriptional silencing in higher organ-
isms  remains  controversial,  despite  the  observation  of 
transcriptional  gene  silencing  on  application  of  small 
RNAs  in  some  human  cell  lines.  Transfection  of  short 
double-stranded RNA corresponding to transcription start 
sites and promoter regions leads to gene silencing in some 
instances (Janowski et al, 2005; Suzuki et al, 2005). Pep- 
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tide nucleic acids (PNA) targeted to the same sequence as 
such ‘antigene’ (agRNAs) provide a similar level of tran-
scriptional inhibition through a mechanism that  may  in-
volve  direct  binding  to  either  single  or  double  stranded 
genomic DNA (Janowski et  al, 2005). Given the  strong 
indication that components of the RNAi pathway are in-
volved in RNAi-TGS, the question of whether such agR-
NAs are acting through an endogenous mechanism or by 
steric interference remains to be addressed – as must be 
conflicting  reports  indicating  that  agRNAs  may  induce 
DNA  methylation.  It  may  be  noteworthy  that  agRNAs 
appear  slightly  more  effective  at  inhibiting  transcription 
that their PNA counterparts, though activity varies signifi-
cantly depending on the sequence chosen (Janowski et al, 
2005). If an endogenous mechanism exists, selection of a 
‘natural’ target site might provide a more obvious differ-
ence in activities between agRNAs and PNAs.  
 
There are many difficulties in delineating the mechanisms 
behind  the  observed  effects  in  immortalized  cell  lines. 
Precise  definition  of  transcriptional  start  sites  for  many 
genes  is  required  to  eliminate  an  mRNA  or  pre-mRNA 
based effect. Reports employing genomic scanning arrays 
suggest  low-level  sense  and  antisense  non-coding  tran-
scription across a large number of genomic loci, and so an 
in-depth characterization  of transcription around a  small 
RNA target site is especially important in understanding 
how the effector oligonucleotide interacts with the target 
(Kapranoc et al, 2005).  
 
Another issue of interest in these reports is the discrepancy 
in the ability to immunoprecipitate AGO2 at target pro-
moters - Janaowski et al detect AGO2 at their target pro-
moters, whilst and Kim et al find no enrichment of AGO2 
by ChIP 18 hrs after dsRNA transfection. If RNA directed 
protein  recruitment  drives  histone  modification,  compo-
nents of the RNAi silencing machinery may be recruited 
to, and then dissociate from, a locus prior to histone modi-
fication – if indeed chromatin modification is dependent 
upon dsRNA at all. Assaying  24-48  hours after dsRNA 
application  might fail to recognize  short term  initial  re-
cruitment of AGO proteins to a target promoter, and so 
lead to the discrepancies observed. 
 
The association of small RNAs with RITS and chromatin 
modifying factors indicates that RNA can direct recruit-
ment of such proteins to sites in genomic DNA (Volpe et 
al 2002). The prospect of designing nucleic acids, or nu-
cleic  acid  mimics  that  might  target  genomic  DNA  and 
modulate transcription offers further scope for developing 
efficient nucleic acid based therapies, and also highlights 
yet another potential role for small RNAs in dampening 
gene transcription. A far more intriguing idea is that small 
RNAs  might  be  involved  not  just  in  silencing,  but also 
transcriptional activation. 
 
RNA activation (‘RNAa’) 
 
An interesting and potentially exciting recent observation 
has been the ability of small RNAs targeted to promoter 
regions to activate transcription (Li et al, 2006). More than 
three decades ago, Britten and Davidson proposed the idea 
that "activator" RNAs, derived from non-coding genomic 
regions, might activate transcription of a number of pro-
tein coding genes (Britten and Davidson, 1969). Li et al 
(2006) now describe activation of transcription at the E-
Cadherin, p21 and VEGF loci in mammalian cells through 
transfection of small dsRNAs. Although the authors were 
not able to predict the gene activating ability of these pro-
moter targetted dsRNAs, they did observe an apparent bias 
in activity based upon the strand loading characteristics of 
AGO proteins, implying that these dsRNAs might interact 
with some components of the RNAi machinery.  
 
A commonality in current reports of transcriptional activa-
tion is the presence of retrotransposon or CpG repeat se-
quences in the promoter regions of such genes. As with 
transcriptional silencing, an understanding of the transcrip-
tional activity in the region of the siRNA target sites is 
crucial in understanding by what means the observed ef-
fect is mediated. Many reports of transcriptional modula-
tion by small RNAs concern promoters in  CpG or trans-
poson rich regions, and the inherent transcriptional silenc-
ing properties of these elements is poorly described - with 
some evidence linking the processing of such repeat se-
quences  to  the  RNAi  machinery  (Yang  and  Kazazian, 
2006). The binding of small RNAs nearby these chromatin 
silencing elements might disrupt their repressive activity 
and in itself lead to gene activation - without requiring a 
novel RNAi effect. Such silencing of silencers may still 
prove important, however, as CpG repeats have been esti-
mated  present  at  greater  than  50%  of  human  gene  pro-
moter regions. 
 
An  increasingly  relevant  observation  in  many  immortal 
cell lines is the broad upregulation of transcription across 
many loci. It is not clear whether such loss of transcrip-
tional  dampening  is  a  consequence  of  immortalisation, 
necessary  to  enhance  the  likelihood  of  a  cell  becoming 
immortalised, or due to experimental selection for rapidly 
dividing cells - but it has important implications for stud-
ies of transcriptional silencing and activation. Selection of 
cells in culture must be avoided; it must be carefully dem-
onstrated that cells expressing higher levels of specific or 
global transcripts are not selected for due to toxicity of a 
specific siRNA transfection, as this may lead to apparent 
changes  in  transcription  at  assayed  loci.  Rescue  experi-
ments  that  alter  the  target,  and  then  compensate  with 
changes in the small RNA effector, provide more convinc-
ing proof, as the unpredictable off-target effects of small 
RNA sequences that might alter the translation of many 
proteins still complicate attribution of observed effects to a 
specific interaction. 
 
The binding of small RNAs to promoters also has the abil-
ity to displace transcriptional activators or repressors in a 
manner that is not limited specifically to the target site, 
and  may  be translated some distance  up  or  downstream 
through the effect of target site  binding on adjacent se-
quences. Current reports have not been able to correlate 
activity of promoter targeted siRNAs to inhibition of tran-
scription  factor  binding  or  polymerase  seating.  Li  et  al 
(2006) also pertinently note that the apparent involvement 
of AGO proteins in transcriptional regulation suggests new 
complications in designing effector RNAs, as ~7-8 nt seed 
sequence recognition may be sufficient to target the pro- 
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moters  of  many  other  genes,  leading  to  unwanted  off-
target effects. 
 
Sequence  and  temporally  specific  transcriptional  activa-
tion by small RNAs indicates the potential for a nuclear 
transcriptional regulatory network perhaps as complex as 
that mediated by protein factors. The complementary base 
specificity of nucleic acids might enhance the fidelity of 
such regulation, and also provides researchers with highly 
discriminative targets for manipulating levels of transcrip-
tion. The application of small dsRNAs to silence or acti-
vate gene transcription may also, however, face inherent 
obstacles  relative  to  cytoplasmic  post-transcriptional 
RNAi  –  such  as  achieving  efficient  nuclear  import  and 
identifying highly inhibitory target sites - yet if a mecha-
nism of RNAi-based transcriptional control proves com-
patible with small RNAs then it will provide a new and 
powerful tool for manipulating gene expression. Unambi-
guous  proof  of  a  small  RNA  transcriptional  regulatory 
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